REHOVOT, Israel, July 20, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading company for
the improvement of crop productivity and economics for food, feed and biofuel industries, announced today that it will release its
financial results for the second quarter of 2017 on Thursday, August 10, 2017.
On the day of the announcement, the Company’s management will host a conference call to discuss the results at
09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial 1-888-668-9141 toll free from the United
States, or +972-3-918-0644 internationally. Access to the call will also be available via live webcast through the Company’s
website at www.evogene.com.
A replay of the conference call will be available approximately three hours following the completion of the
call. To access the replay, please dial 1-888-254-7270 toll free from the United States, or +972-3-925-5940 internationally. The
replay will be accessible through August 12, 2017, and an archive of the webcast will be available on the Company’s website through
August 20, 2017.
About Evogene Ltd.:
Evogene (NASDAQ:EVGN) (TASE:EVGN) is a leading biotechnology company for the improvement of crop productivity for the food, feed
and fuel industries. The Company operates in three key target markets: improved seed traits (addressing yield increase, tolerance
to environmental stresses and resistance to insects and diseases); innovative ag-chemicals (developing novel herbicide solutions
for weed control); and ag-biologicals. Evogene has collaborations with world-leading seed and ag-chemical companies. For more
information, please visit www.evogene.com or contact the Company at info@evogene.com.
Forward Looking Statements:
This press release contains “forward-looking statements” relating to future events. These statements may be identified by words
such as “may”, “could”, “expects”, "intends", “anticipates”, “plans”, “believes”, “scheduled”, “estimates” or words of similar
meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future
events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance.
Therefore, actual future results, performance or achievements of Evogene may differ materially from what is expressed or implied by
such forward-looking statements due to a variety of factors, many of which beyond Evogene's control, including, without limitation,
those risk factors contained in Evogene’s reports filed with the appropriate securities authority. Evogene disclaims any obligation
or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations,
estimates, projections and assumptions.
Contact: Alex Taskar Chief Financial Officer E: IR@evogene.com T: (+972)-8-931-1963
